# Boston Scientific Corporation (BSX) — Q1-2017 Earnings Results

**Report date:** 2017-04-27 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q1-2017

## Post-Earnings Brief

### Headline

Boston Scientific Misses on EPS, Stock Up 0.81%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.29 | N/A | -4.55% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about future prospects. They emphasized their commitment to innovation and growth.

**Key quotes:**

> Management highlighted ongoing investments in innovation.

> They expressed confidence in long-term growth despite current challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's earnings report showed a slight miss on EPS, which may raise some concerns among investors. However, the stock reacted positively, gaining 0.81%, likely due to management's focus on innovation and long-term growth strategies. The lack of revenue data and guidance leaves some uncertainty for future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q1-2017_